CELGENE CORPORATION for CELGENE CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2015 | $730,000 | Replaced |
| 2nd Quarter - Amendment | Jan 27, 2016 | $830,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
HR 9, "Innovation Act", provisions regarding patent reform. S 632, "STRONG Patents Act", provisions regarding patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Health Issues HCR
HR 2841, "FAST Generic Act of 2015", regarding all provisions. HR 2739/S 1566, "Cancer Drug Coverage Parity Act", regarding all provisions. HR 1600, "Patients Access To Treatments Act", regarding all provisions. HR 6, "21st Century Cures", regarding all provisions. Issues related to Medicare Part D/Part B. Issues related to the Afforable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN EISENBERG | — |
| PATRICK GLIHA | — |
| MATTHEW SCHUMAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.